GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Beijing Strong Biotechnologies Inc (SZSE:300406) » Definitions » Cyclically Adjusted Book per Share

Beijing Strong Biotechnologies (SZSE:300406) Cyclically Adjusted Book per Share : ¥4.06 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Beijing Strong Biotechnologies Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Beijing Strong Biotechnologies's adjusted book value per share for the three months ended in Mar. 2024 was ¥6.539. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥4.06 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Beijing Strong Biotechnologies's average Cyclically Adjusted Book Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-06-08), Beijing Strong Biotechnologies's current stock price is ¥17.31. Beijing Strong Biotechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥4.06. Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio of today is 4.26.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Beijing Strong Biotechnologies was 6.34. The lowest was 4.18. And the median was 5.03.


Beijing Strong Biotechnologies Cyclically Adjusted Book per Share Historical Data

The historical data trend for Beijing Strong Biotechnologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Strong Biotechnologies Cyclically Adjusted Book per Share Chart

Beijing Strong Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3.56 3.98

Beijing Strong Biotechnologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.69 3.79 3.88 3.98 4.06

Competitive Comparison of Beijing Strong Biotechnologies's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio falls into.



Beijing Strong Biotechnologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beijing Strong Biotechnologies's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.539/115.2271*115.2271
=6.539

Current CPI (Mar. 2024) = 115.2271.

Beijing Strong Biotechnologies Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.156 98.200 1.356
201409 1.270 98.900 1.480
201412 1.983 99.000 2.308
201503 2.093 99.900 2.414
201506 2.073 99.500 2.401
201509 2.244 100.500 2.573
201512 2.352 100.600 2.694
201603 2.484 102.200 2.801
201606 2.455 101.400 2.790
201609 2.607 102.400 2.934
201612 2.777 102.600 3.119
201703 2.878 103.200 3.213
201706 2.696 103.100 3.013
201709 2.863 104.100 3.169
201712 3.049 104.500 3.362
201803 3.116 105.300 3.410
201806 2.994 104.900 3.289
201809 3.180 106.600 3.437
201812 3.392 106.500 3.670
201903 3.521 107.700 3.767
201906 3.517 107.700 3.763
201909 3.691 109.800 3.873
201912 3.928 111.200 4.070
202003 3.962 112.300 4.065
202006 3.857 110.400 4.026
202009 5.380 111.700 5.550
202012 5.429 111.500 5.610
202103 5.619 112.662 5.747
202106 5.714 111.769 5.891
202109 5.885 112.215 6.043
202112 4.880 113.108 4.971
202203 5.042 114.335 5.081
202206 5.073 114.558 5.103
202209 5.352 115.339 5.347
202212 5.555 115.116 5.560
202303 5.742 115.116 5.748
202306 5.885 114.558 5.919
202309 6.082 115.339 6.076
202312 6.330 114.781 6.355
202403 6.539 115.227 6.539

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Beijing Strong Biotechnologies  (SZSE:300406) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Beijing Strong Biotechnologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=17.31/4.06
=4.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Beijing Strong Biotechnologies was 6.34. The lowest was 4.18. And the median was 5.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Beijing Strong Biotechnologies Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Strong Biotechnologies (SZSE:300406) Business Description

Traded in Other Exchanges
N/A
Address
No. 15 Hua Yuan Dong Lu, 5th Floor, Kuang Yi Building, Haidian District, Beijing, CHN, 100191
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Executives
Shuang He Executives
Luo Ai Ping Director
Directors, executives
Liu Wei Executives
Zhou Ming Executives
Zhuang Xian Min Directors, executives
Zhang Yi Executives
Liu Xi Directors, executives
Sun Xiao Lin Director
Yu Jian Ping Executives

Beijing Strong Biotechnologies (SZSE:300406) Headlines

No Headlines